The CDK4/6 inhibitors biomarker landscape: The most relevant biomarkers of response or resistance for further research and potential clinical utility.

导出 LinkOut

翻译打印收藏纠错

作者： Gabriele,Antonarelli ^[1] ; Beatrice,Taurelli Salimbeni ^[2] ; Antonio,Marra ^[2] ; Angela,Esposito ^[2] ; Marzia Adelia,Locatelli ^[2] ; Dario,Trapani ^[1] ; Carlo,Pescia ^[3] ; Nicola,Fusco ^[4] ; Giuseppe,Curigliano ^[1] ; Carmen,Criscitiello ^[5]

作者单位： Department of Oncology and Haemato-Oncology (DIPO), University of Milan, Milan, Italy; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy. ^[1] Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy. ^[2] Division of Pathology, European Institute of Oncology (IEO), IRCCS, Milan, Italy. ^[3] Department of Oncology and Haemato-Oncology (DIPO), University of Milan, Milan, Italy; Division of Pathology, European Institute of Oncology (IEO), IRCCS, Milan, Italy. ^[4] Department of Oncology and Haemato-Oncology (DIPO), University of Milan, Milan, Italy; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: carmen.criscitiello@ieo.it. ^[5]

关键词 Breast Cancer Cyclin-Dependent Kinase inhibitors Endocrine Resistance Molecular Biomarkers

主题词人类(Humans);女(雌)性(Female);细胞周期蛋白依赖激酶4(Cyclin-Dependent Kinase 4);细胞周期蛋白依赖激酶6(Cyclin-Dependent Kinase 6);乳腺肿瘤(Breast Neoplasms);蛋白激酶抑制剂(Protein Kinase Inhibitors)

DOI 10.1016/j.critrevonc.2023.104148

PMID 37783318

发布时间 2023-11-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交